Klingebiel T - Search Results

1

Peripheral stem cell transplantation in neuroblastoma stage 4 with the use of [131I-m]IBG.

Klingebiel T, Handgretinger R, Herter M, Lang P, Dopfer R, Scheel-Walter H, Niethammer D. Klingebiel T, et al. Prog Clin Biol Res. 1994;385:309-17. Prog Clin Biol Res. 1994. PMID: 7972226 Clinical Trial. No abstract available.

2

Peripheral stem cell collection and transplantation in pediatric patients.

Handgretinger R, Klingebiel T, Dopfer R, Siedner R, Baden B, Wendt S, Scheel-Walter HG, Scheel P, Schlander M, Niethammer D. Handgretinger R, et al. Among authors: klingebiel t. Prog Clin Biol Res. 1992;377:615-20. Prog Clin Biol Res. 1992. PMID: 1359568 No abstract available.

3

Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.

Klingebiel T, Feine U, Treuner J, Reuland P, Handgretinger R, Niethammer D. Klingebiel T, et al. J Nucl Biol Med (1991). 1991 Oct-Dec;35(4):216-9. J Nucl Biol Med (1991). 1991. PMID: 1823821

4

Irradiation of human neuroblastoma cell lines by [131I-m]iodobenzylguanidine.

Klingebiel T, Bruchelt G, Kaulich T, Smykowski H, Treuner J, Niethammer D. Klingebiel T, et al. Prog Clin Biol Res. 1991;366:487-93. Prog Clin Biol Res. 1991. PMID: 2068164 No abstract available.

5

[131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.

Klingebiel T, Treuner J, Ehninger G, Keller KD, Dopfer R, Feine U, Niethammer D. Klingebiel T, et al. Cancer Chemother Pharmacol. 1989;25(2):143-8. doi: 10.1007/BF00692356. Cancer Chemother Pharmacol. 1989. PMID: 2598401

6

Autologous transplantation with peripheral blood stem cells in children and young adults after myeloablative treatment: nonrandomized comparison between GM-CSF and G-CSF for mobilization.

Klingebiel T, Handgretinger R, Herter M, Eppinger T, Bader P, Lang P, Dopfer R, Scheel-Walter H, Haus U, Niethammer D. Klingebiel T, et al. J Hematother. 1995 Aug;4(4):307-14. doi: 10.1089/scd.1.1995.4.307. J Hematother. 1995. PMID: 7489145 Clinical Trial.

7

[Follow-up evaluation of metastatic neuroblastoma using high dose [131I-meta]iodobenzylguanidine].

Klingebiel T, Reuland P, Feine U, Niethammer D. Klingebiel T, et al. Nuklearmedizin. 1992 Dec;31(6):209-12. Nuklearmedizin. 1992. PMID: 1491958 German.

8

A phase I study of neuroblastoma with the anti-ganglioside GD2 antibody 14.G2a.

Handgretinger R, Baader P, Dopfer R, Klingebiel T, Reuland P, Treuner J, Reisfeld RA, Niethammer D. Handgretinger R, et al. Among authors: klingebiel t. Cancer Immunol Immunother. 1992;35(3):199-204. doi: 10.1007/BF01756188. Cancer Immunol Immunother. 1992. PMID: 1638557 Free PMC article. Clinical Trial.

9

Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.

Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, Feine U, Maul FD, Waters W, Wehinger H, Niethammer D. Klingebiel T, et al. Med Pediatr Oncol. 1991;19(2):84-8. doi: 10.1002/mpo.2950190203. Med Pediatr Oncol. 1991. PMID: 2011100

10

Opioid peptides as possible cause of pain reduction in neuroblastoma after admission of 131I-meta-iodobenzylguanidine.

Klingebiel T, Bruchelt G, Kaleva N, Wollmann H, Handgretinger R, Treuner J, Gupta D, Niethammer D. Klingebiel T, et al. Prog Clin Biol Res. 1991;366:509-12. Prog Clin Biol Res. 1991. PMID: 2068167 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

561 results

Search Page

Filters